Spring sale! Get NewsNow Essentials at just £2.99 a month (40% OFF!). Faster, slicker, customisable & ads free!Spring sale! Get NewsNow Essentials at just £2.99 a month (40% OFF!). Go ads free today!Spring sale! Upgrade now at £2.99/m (40% OFF!)

Home
Hot Topics
UK
World
Gaza
Ukraine
Iran
Climate Crisis
Business
Football
Sport
Entertainment
Tech
Science

Valneva
Pharmaceuticals
Pfizer
AstraZeneca
Johnson and Johnson
Novo Nordisk
Sanofi
GSK
AbbVie
Bristol Myers Squibb
Roche
Topics

Advertisement

Valneva

Share

Advertisement

Advertisement

Latest

Thursday

Valneva Announces the Successful Completion of an €84 million Reserved Offering Valneva (Press Release) 06:16 Thu, 30 Apr

In the last month

A vaccine for Lyme disease could be on the horizon Science News Online 14:02 Mon, 20 Apr

Advertisement

Advertisement

Advertisement

Advertisement

Valneva News

Latest news on Valneva, a French biotech company that develops and commercialises vaccines for infectious diseases.

NewsNow

Our Sites

NewsNow Nigeria

NewsNow România

NewsNow Australia

Work with us

Publisher Network

Dockside Online IDE

Legal

Subscription Terms

© Copyright 1997 - 2026 NewsNow Publishing Limited. All rights reserved.

Back to Industry Sectors Pharmaceuticals
- Abbott Laboratories
- AbbVie AbbVie
- AstraZeneca
- Baxter Baxter
- Bayer Bayer
- Boehringer Ingelheim
- Bristol Myers Squibb
- Eli Lilly Eli Lilly
- Genentech Genentech
- GlaxoSmithKline
- Johnson and Johnson
- Merck and Co
- Novartis Novartis
- Novavax Novavax
- Novo Nordisk
- Pfizer Pfizer
- Roche Roche
- Sanofi Sanofi
- Shire Shire
- Takeda Takeda
- Teva Teva
- Valneva Valneva
- Zoetis Zoetis